Clinical Characteristics and Prognosis of Differentiated Thyroid Carcinoma with Small Foci of Anaplastic Transformation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: Anaplastic thyroid carcinoma (ATC) is commonly related with concurrent differentiated thyroid carcinoma (DTC). We aimed to examine the clinicopathologic characteristics, prognosis and gene expression of DTC with anaplastic foci. Materials and Methods: Eighteen patients with DTC with anaplastic foci were enrolled in this study. To compare the clinicopathologic characteristics and prognosis of anaplastic foci subjects with conventional ATC or DTC, we additionally included 12 ATC and 1030 DTC patients who diagnosed during same period. Immunohistochemistry was performed to check the gene expression in anaplastic foci and DTC component. Results: In anaplastic foci group, tumor size was larger (2.5±1.3 vs. 1.2±0.9 cm, p=0.001), distant metastasis was more frequent (11.1 vs. 0%, p=0.000) and 1-year survival rate was low (88.9 vs. 100%, p=0.000) than DTC group. In contrast, compared with ATC group, anaplastic foci group showed younger age at diagnosis (50±16 vs. 63±18 years, p=0.039), smaller tumor size (2.5±1.3 vs. 3.8±1.4 cm, p=0.027), less distant metastasis (11.1 vs. 41.7%, p=0.084) and longer 1-year survival rate (88.9 vs. 25.0%, p=0.001). Expression of p53 protein was observed in 100% of anaplastic foci, ATC and 12.5% of papillary thyroid carcinoma component. Conclusion: DTC with foci of anaplastic transformation has a worse prognosis than DTC, but a better prognosis than ATC. Our results support that DTC with anaplastic foci was intermediate state from DTC to ATC.
Abstract
Background and Objectives: Anaplastic thyroid carcinoma (ATC) is commonly related with concurrent differentiated thyroid carcinoma (DTC). We aimed to examine the clinicopathologic characteristics, prognosis and gene expression of DTC with anaplastic foci. Materials and Methods: Eighteen patients with DTC with anaplastic foci were enrolled in this study. To compare the clinicopathologic characteristics and prognosis of anaplastic foci subjects with conventional ATC or DTC, we additionally included 12 ATC and 1030 DTC patients who diagnosed during same period. Immunohistochemistry was performed to check the gene expression in anaplastic foci and DTC component. Results: In anaplastic foci group, tumor size was larger (2.5±1.3 vs. 1.2±0.9 cm, p=0.001), distant metastasis was more frequent (11.1 vs. 0%, p=0.000) and 1-year survival rate was low (88.9 vs. 100%, p=0.000) than DTC group. In contrast, compared with ATC group, anaplastic foci group showed younger age at diagnosis (50±16 vs. 63±18 years, p=0.039), smaller tumor size (2.5±1.3 vs. 3.8±1.4 cm, p=0.027), less distant metastasis (11.1 vs. 41.7%, p=0.084) and longer 1-year survival rate (88.9 vs. 25.0%, p=0.001). Expression of p53 protein was observed in 100% of anaplastic foci, ATC and 12.5% of papillary thyroid carcinoma component. Conclusion: DTC with foci of anaplastic transformation has a worse prognosis than DTC, but a better prognosis than ATC. Our results support that DTC with anaplastic foci was intermediate state from DTC to ATC.
참고문헌 (23)
- Pasieka JL, "Anaplastic thyroid cancer", Curr Opin Oncol, 15(1), pp.78~83 (2003)
- Haigh PI, "Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival", Cancer, 91(12), pp.2335~2342 (2001)
- Kim TY, "Prognostic factors for Korean patients with anaplastic thyroid carcinoma", Head Neck, 29(8), pp.765~772 (2007)
- Sugitani I, "Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients", World J Surg, 36(6), pp.1247~1254 (2012)
- Spires JR, "Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer", Arch Otolaryngol Head Neck Surg, 114(1), pp.40~44 (1988)
- Hunt JL, "Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid", Am J Surg Pathol, 27(12), pp.1559~1564 (2003)
- Tan RK, "Anaplastic carcinoma of the thyroid: a 24-year experience", Head Neck, 17(1), pp.41~47 (1995)
- McIver B, "Anaplastic thyroid carcinoma: a 50-year experience at a single institution", Surgery, 130(6), pp.1028~1034 (2001)
- Wiseman SM, "Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma", Arch Surg, 142(8), pp.717~727 (2007)
- Albores-Saavedra J, "Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study", Endocr Pathol, 18(1), pp.1~7 (2007)
- Han JM, "Time trend in tumour size and characteristics of anaplastic thyroid carcinoma", Clin Endocrinol (Oxf), 77(3), pp.459~464 (2012)
- Wiseman SM, "Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction", Arch Otolaryngol Head Neck Surg, 129(1), pp.96~100 (2003)
- Sugitani I, "Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid", World J Surg, 25(5), pp.617~622 (2001)
- Ibanez ML, "Thyroid carcinoma--biologic behavior and mortality. Postmortem findings in 42 cases, including 27 in which the disease was fatal", Cancer, 19(8), pp.1039~1052 (1966)
- Xing M, "BRAF mutation in thyroid cancer", Endocr Relat Cancer, 12(2), pp.245~262 (2005)
- Quiros RM, "Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations", Cancer, 103(11), pp.2261~2268 (2005)
- Nikiforova MN, "BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas", J Clin Endocrinol Metab, 88(11), pp.5399~5404 (2003)
- Nilsson O, "Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period", World J Surg, 22(7), pp.725~730 (1998)
- Sugino K, "The important role of operations in the management of anaplastic thyroid carcinoma", Surgery, 131(3), pp.245~ (2002)
- Neff RL, "Anaplastic thyroid cancer", Endocrinol Metab Clin North Am, 37(2), pp.525~538 (2008)
- O'Neill JP, "Anaplastic thyroid cancer, tumorigenesis and therapy", Ir J Med Sci, 179(1), pp.9~15 (2010)
- Smallridge RC, "American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer", Thyroid, 22(11), pp.1104~1139 (2012)
- Lee DY, "Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma", Thyroid, 26(3), pp.404~413 (2016)